WayPoint Biomedical Holdings, Inc. (WYPH)

Market Cap	16.68K
Revenue (ttm)	33.24K
Net Income (ttm)	-806.27K
Shares Out	55.60M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Average Volume	38,159
Open	0.0003
Previous Close	n/a
Day's Range	0.0003 - 0.0003
52-Week Range	0.0001 - 0.0021
Beta	-93.53
RSI	46.07
Earnings Date	n/a

About WYPH

WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2004
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: WYPH